A Compilation of Drug Etiologies of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
Isaac T Abulatan, Sage G Ben-David, Lery A Morales-Colon, Elisabeth Beason, Adegbenro O Fakoya
Cureus. 2023 Nov; 15(11): e48728. Published online 2023 Nov 13. doi: 10.7759/cureus.48728
PMCID: PMC10718167
AbstractArticlePDF–251K
Select item 99329452.
Worldwide Prevalence of Antibiotic-Associated Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Systematic Review and Meta-analysis
Erika Yue Lee, Christopher Knox, Elizabeth Jane Phillips
JAMA Dermatol. 2023 Apr; 159(4): 384–392. Published online 2023 Feb 15. doi: 10.1001/jamadermatol.2022.6378
PMCID: PMC9932945
AbstractArticle
Select item 112135023.
Greater mechanistic understanding of the cutaneous pathogenesis of Stevens–Johnson syndrome/toxic epidermal necrolysis can shed light on novel therapeutic strategies: a comprehensive review
Emeka D. Ogiji, Nourah Aboheimed, Kehinde Ross, Calum Voller, Ryan Siner, Rebecca L. Jensen, Carol E. Jolly, Daniel F. Carr
Curr Opin Allergy Clin Immunol. 2024 Aug; 24(4): 218–227. Published online 2024 May 17. doi: 10.1097/ACI.0000000000000993
PMCID: PMC11213502
AbstractArticlePDF–1.2M
Select item 94498014.
Stevens-Johnson syndrome and toxic epidermal necrolysis: A systematic review of PubMed/MEDLINE case reports from 1980 to 2020
Liqin Wang, Sheril Varghese, Fatima Bassir, Ying-Chin Lo, Carlos A. Ortega, Sonam Shah, Kimberly G. Blumenthal, Elizabeth J. Phillips, Li Zhou
Front Med (Lausanne) 2022; 9: 949520. Published online 2022 Aug 24. doi: 10.3389/fmed.2022.949520
PMCID: PMC9449801
AbstractArticlePDF–2.6M
Select item 101575995.
Ophthalmic Aspects of Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: A Narrative Review
Gábor Tóth, Andrea Lukács, Frank Schirra, Gábor L. Sándor, Petra Killik, Otto A. Maneschg, Zoltán Z. Nagy, Nóra Szentmáry
Ophthalmol Ther. 2023 Aug; 12(4): 1795–1811. Published online 2023 May 4. doi: 10.1007/s40123-023-00725-w
PMCID: PMC10157599
AbstractArticlePDF–947K
Select item 114418656.
Stevens–Johnson syndrome and toxic epidermal necrolysis: Updates in pathophysiology and management
Akito Hasegawa, Riichiro Abe
Chin Med J (Engl) 2024 Oct 5; 137(19): 2294–2307. Published online 2024 Sep 5. doi: 10.1097/CM9.0000000000003250
PMCID: PMC11441865
AbstractArticlePDF–4.1M
Select item 73089947.
Recent advances in managing and understanding Stevens-Johnson syndrome and toxic epidermal necrolysis
Akito Hasegawa, Riichiro Abe
Version 1. F1000Res. 2020; 9: F1000 Faculty Rev-612. Published online 2020 Jun 16. doi: 10.12688/f1000research.24748.1
PMCID: PMC7308994
AbstractArticlePDF–1.0M
Select item 84720078.
Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: A Review of Diagnosis and Management
Robert Frantz, Simo Huang, Abhirup Are, Kiran Motaparthi
Medicina (Kaunas) 2021 Sep; 57(9): 895. Published online 2021 Aug 28. doi: 10.3390/medicina57090895
PMCID: PMC8472007
AbstractArticlePDF–1.5M
Select item 72363949.
Multidisciplinary care in Stevens-Johnson syndrome
Swapna S. Shanbhag, James Chodosh, Cherie Fathy, Jeremy Goverman, Caroline Mitchell, Hajirah N. Saeed
Ther Adv Chronic Dis. 2020; 11: 2040622319894469. Published online 2020 Apr 28. doi: 10.1177/2040622319894469
PMCID: PMC7236394
AbstractArticlePDF–1.7M
Select item 1025900410.
Photodistributed Stevens–Johnson syndrome and toxic epidermal necrolysis: a systematic review and proposal for a new diagnostic classification
Blake Jeffrey McKinley, Mitchell Edger Allen, Nicole Michels
Eur J Med Res. 2023; 28: 188. Published online 2023 Jun 12. doi: 10.1186/s40001-023-01142-2
PMCID: PMC10259004
AbstractArticlePDF–1.3M
Select item 1120711511.
Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: Analysis of the Russian Database of Spontaneous Reports
Sergey Zyryanov, Irina Asetskaya, Olga Butranova, Elizaveta Terekhina, Vitaly Polivanov, Alexander Yudin, Kristina Samsonova
Pharmaceuticals (Basel) 2024 Jun; 17(6): 675. Published online 2024 May 24. doi: 10.3390/ph17060675
PMCID: PMC11207115
AbstractArticlePDF–1.3M
Select item 749667612.
Clinical and pathogenic aspects of the severe cutaneous adverse reaction epidermal necrolysis (EN)
E.C. Kuijper, L.E. French, C.P. Tensen, M.H. Vermeer, J.N. Bouwes Bavinck
J Eur Acad Dermatol Venereol. 2020 Sep; 34(9): 1957–1971. Published online 2020 May 15. doi: 10.1111/jdv.16339
PMCID: PMC7496676
AbstractArticlePDF–644K
Select item 743197013.
Pediatric SJS-TEN: Where are we now?
Michele Ramien, Jennifer L. Goldman
Version 1. F1000Res. 2020; 9: F1000 Faculty Rev-982. Published online 2020 Aug 13. doi: 10.12688/f1000research.20419.1
PMCID: PMC7431970
AbstractArticlePDF–787K
Select item 661779114.
Serum and blister‐fluid elevation and decreased epidermal content of high‐mobility group box 1 protein in drug‐induced Stevens–Johnson syndrome/toxic epidermal necrolysis
D.F. Carr, C.‐W. Wang, T. Bellón, L. Ressel, G. Nwikue, V. Shrivastava, W. Bergfeld, A.L. Jorgensen, W.‐H. Chung, M. Pirmohamed
Br J Dermatol. 2019 Jul; 181(1): 166–174. Published online 2019 Mar 26. doi: 10.1111/bjd.17610
PMCID: PMC6617791
AbstractArticlePDF–866K
Select item 881478415.
Culprit Medications and Risk Factors Associated with Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: Population-Based Nested Case–Control Study
Naomi Gronich, David Maman, Nili Stein, Walid Saliba
Am J Clin Dermatol. 2022; 23(2): 257–266. Published online 2022 Feb 4. doi: 10.1007/s40257-021-00661-0
PMCID: PMC8814784
AbstractArticlePDF–1007K
Select item 838793816.
Assessment of Treatment Approaches and Outcomes in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: Insights From a Pan-European Multicenter Study
Khalaf Kridin, Marie-Charlotte Brüggen, Ser-Ling Chua, Anette Bygum, Sarah Walsh, Mirjam C. Nägeli, Vesta Kucinskiene, Lars French, Florence Tétart, Biagio Didona, Brigitte Milpied, Annamari Ranki, Carmen Salavastru, Eva Březinová, Sapna Divani-Patel, Tine Lorentzen, Julie Loft Nagel, Skaidra Valiukeviciene, Viktorija Karpavičiūtė, George-Sorin Tiplica, Eva Oppel, Anna Oschmann, Nicolas de Prost, Artem Vorobyev, Saskia Ingen-Housz-Oro
JAMA Dermatol. 2021 Oct; 157(10): 1–9. Published online 2021 Aug 25. doi: 10.1001/jamadermatol.2021.3154
PMCID: PMC8387938
AbstractArticle
Select item 1028567817.
Assessment of Need for Improved Identification of a Culprit Drug in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis
Dayan J. Li, Gustavo A. Velasquez, George A. Romar, Elisa M. Schunkert, Ruth K. Foreman, Sherrie J. Divito
JAMA Dermatol. 2023 Aug; 159(8): 830–836. Published online 2023 Jun 21. doi: 10.1001/jamadermatol.2023.1693
PMCID: PMC10285678
AbstractArticle
Select item 1132674918.
Allopurinol: Clinical Considerations in the Development and Treatment of Stevens-Johnson Syndrome, Toxic Epidermal Necrolysis, and Other Associated Drug Reactions
Kathryn M Dillman, Alison M Hawkins, Amanda R Ragland, Grace C Wester, Driskell R Greene, Giustino Varrassi, Peyton Moore, Raju Behara, Shahab Ahmadzadeh, Harish Siddaiah, Sahar Shekoohi, Alan D Kaye
Cureus. 2024 Jul; 16(7): e64654. Published online 2024 Jul 16. doi: 10.7759/cureus.64654
PMCID: PMC11326749
AbstractArticlePDF–219K
Select item 966648819.
Visual function and quality of life in patients with Stevens-Johnson syndrome who received acute protocol-based ocular care
Swapna S. Shanbhag, Mohammad A. Tahboub, James Chodosh, Hajirah N. Saeed
Front Toxicol. 2022; 4: 992696. Published online 2022 Nov 2. doi: 10.3389/ftox.2022.992696
PMCID: PMC9666488
AbstractArticlePDF–796K
Select item 729767820.
Acute pancreatic injuries: A complication of Stevens-Johnson syndrome/toxic epidermal necrolysis associated with cytotoxic immunocell activation
Xuemei Gao, Xuhua Tang, Lu Ai, Qian Gao, Qiman Liao, Mukai Chen, Xiaohong Chen, Hui Zhou, Yanting Ye, Minyi Li, Jiande Han, Fang Wang
J Am Acad Dermatol. 2021 Mar; 84(3): 644–653. Published online 2020 Jun 17. doi: 10.1016/j.jaad.2020.06.043
PMCID: PMC7297678
AbstractArticlePDF–1.1M
Copyright © 2025 Stevens Johnson Syndrome - All Rights Reserved.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.